Printer Friendly

MERIDIAN SIGNS EXCLUSIVE LICENSE FOR TWO NEW PRODUCTS

 CINCINNATI, Jan. 19 /PRNewswire/ -- Meridian Diagnostics (NASDAQ/NMS: KITS), today signed a long-term agreement covering world- wide exclusive rights (except Brazil) to manufacture, sell, market and distribute two new products from Tacoma Trading Corporation, a Michigan company. The products are a patented parasitology concentration and transport system and a urine transport system. The company expects to begin marketing activities within thirty days.
 Jerry L. Ruyan, chief executive officer, said, "The addition of the parasitology product further enhances our leading position in parasite preservation, transportation and identification systems. The urine transport system offers an opportunity to enter a new market for the company and build on our growing urinary tract infection identification business."
 William J. Motto, chairman, said, "These two products are further examples of how we are continuing to build the company by acquiring products, product lines and technology."
 Meridian Diagnostics, Inc. develops, manufactures and markets a variety of immunodiagnostic test kits, purified reagents such as antigens and monoclonal and polyclonal antibodies, and related diagnostic products. The company is a leader in the area of rapid diagnosis of infectious human diseases. All Meridian products are used outside the human body and require little or no special instrumentation or equipment. Domestic and international market segments consist of hospital, commercial and reference laboratories, and physicians' offices. The company has a leading market position in fungal serology, and is the leader in parasite and bacterial collection, preservation and transportation systems. The company's shares are traded through NASDAQ/NMS (symbol: KITS).
 -0- 1/19/93
 /CONTACT: Jerry L. Ruyan, chief executive officer, Meridian Diagnostics, Inc., 513-271-3700/
 (KITS)


CO: Meridian Diagnostics, Inc. ST: Ohio IN: MTC SU: PDT

BM -- CL008 -- 6222 01/19/93 10:24 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 19, 1993
Words:282
Previous Article:HARLAND REPORTS 43RD CONSECUTIVE YEAR OF SALES GAINS
Next Article:VARITY CORPORATION ESTABLISHES A COMMISSION-FREE SELLING PROGRAM FOR ODDLOT HOLDERS
Topics:


Related Articles
MERIDIAN RELEASES FOURTH PREMIER(TM) ENZYME IMMUNOASSAY
MERIDIAN AND ENSYS TO LAUNCH WATER TEST PRODUCTS
CORESTATES COMPLETES MERIDIAN ACQUISITION; EXECUTIVE TRANSITION PLANS ANNOUNCED
Meridian Releases SuperLAT(TM) Gateway
Meridian Medical Technologies Reports Improved First Quarter Sales and Earnings
Meridian Enters Agreement with Mylan for Development of Generic Drug Line
Meridian Projects Strong Growth Opportunities From New Product Developments
MERIDIAN GETS U.K. APPROVAL OF MORPHINE AUTO-INJECTOR.
Polycom Announces SoundStation Premier Interoperable With Nortel Networks Meridian 1 PBX; New SoundStation Premier 550D Is the Industry's First...
Newest Trump venture a sure bet, says banker.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters